While Alzheimer’s is better understood today than in the past, no effective treatments for the disease have yet been found. One major challenge facing Alzheimer’s drug trials is finding participants. As GAP President John Dwyer says, “The biggest problem is that people are not aware of clinical trials. The fact is, the first person to […]
The Acti-v8 Your Brain initiative provides eight ways in which people can make positive lifestyle changes to improve their brain health. This article puts special focus on pillar #8 (participating in Alzheimer’s clinical trials). Read the full story here. […]
In a joint op-ed with George Vradenburg, co-founder of UsAgainstAlzheimer’s, GAP President John Dwyer argues that the Centers for Medicare and Medicaid Services (CMS) has taken an important first step towards improving our health care system’s ability to address Alzheimer’s. By authorizing significant payments for Medicare Advantage beneficiaries with a diagnosis of dementia, CMS has […]
While the Alzheimer’s clinical trials field has seen setbacks recently in studies targeting the elimination of amyloid beta plaques, GAP is pressing full speed ahead towards an Alzheimer’s cure by accelerating current trials, streamlining the trial startup process, and boosting trial recruitment efforts. Read the full story here. […]
Nashville’s largest Catholic newspaper profiled John Dwyer, president of GAP and 1974 graduate of Father Ryan High School, a Catholic school in Nashville. The article covers GAP’s initiatives and quotes Linda Schipani, president and CEO for Clinical Research Associates in Nashville (a GAP-Net site). Read the full article here. […]
This two-part feature covers the 2019 GAP-Net Site Optimization Conference and the many ways in which GAP is bringing its patient-centered, business-oriented approach to improve Alzheimer’s clinical trials. Representatives from several GAP-Net sites are quoted and mentioned in the piece, which details GAP’s effort to boost recruitment and unclog procedural bottlenecks, as well as its […]
In addition to covering the GAP-Net Site Optimization Conference, which took place in Nashville February 27 – March 1, the Nashville Medical News highlighted GAP’s efforts to speed and improve Alzheimer’s clinical trials through better administrative practices, a common IRB, and other disruptive tactics. The piece highlights two GAP-Net sites in Nashville: Clinical Research Associates and the Center for Cognitive […]
This Clinical Neurology News story discusses GAP’s efforts to support and collaborate with “memory fitness programs” through select Medicare Advantage plans to encourage higher participation in Alzheimer’s clinical trials. Read the full story here. […]
GAP President John Dwyer and Dr. Paul Newhouse, director of the GAP-Net site Center for Cognitive Medicine at Vanderbilt University Medical Center (VUMC), published an op-ed speaking to the importance of clinical trial participation in the fight to end Alzheimer’s. The piece, which highlights VUMC’s Alzheimer’s clinical trials, ran just before the 2nd annual GAP-Net Site Optimization […]
Top Alzheimer’s Researchers Hope That Near-100 Dementia Drugs in Trials Are Moving Closer to a Breakthrough The search for a drug to treat Alzheimer’s disease, the most common form of dementia, has been marked by clinical trial failures. A new report from top researchers says the number of drugs advancing through clinical phase two and […]